Form 4: Therapeutic Solutions International CEO Acquires 25 Million Shares
SEC Form 4
Timothy G. Dixon, President & CEO of Therapeutic Solutions International, acquired 25 million shares of common stock at a price of $0.0008 per share on July 8, 2024.
Summary
- On July 8, 2024, Timothy G. Dixon, the President & CEO of Therapeutic Solutions International, acquired 25,000,000 shares of common stock.
- The acquisition price was $0.0008 per share.
- Following the transaction, Mr. Dixon beneficially owns 474,350,245 shares of the company's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While insider buying can be seen as positive, the small price per share and lack of context make it difficult to assess the true impact.
Positives
- The CEO's acquisition of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
This type of SEC filing is standard for corporate insiders who trade in their company's stock. It provides transparency to the market.
Stakeholder Impact
- The increased ownership by the CEO could potentially increase shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 07/08/2024 | Date of the stock transaction. |
Keywords
Therapeutic Solutions International, TSOI, Timothy G. Dixon, stock acquisition, beneficial ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.